Skip to main content

Headlines

Immunovant Announces Positive Initial Data From Phase 1 Study Of IMVT-1402
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Carisma Therapeutics Gets FDA Clearance To Start Phase 1 Study Of CT-0525 In Solid Tumors
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
MorphoSys : Phase 3 Study Of Pelabresib Combination In Myelofibrosis Meets Primary Endpoint
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Bayer Stops Phase III Study Of Asundexian In Atrial Fibrillation Due To Lack Of Efficacy
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Karuna Announces Positive Results From Phase 1b BP Monitoring Trial Of KarXT In Schizophrenia
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Exelixis Announces Encouraging Results From Phase 1b Trial Of Zanzalintinib In Kidney Cancer
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Novartis : Phase III Studies Of Remibrutinib In Chronic Spontaneous Urticaria Meet Main Goal
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
AIM ImmunoTech Announces Positive Data From Phase 2 Study Of Ampligen In Recurrent Ovarian Cancer
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
The Handover Begins: TradFi Takes Center Stage in Crypto’s Next Phase
posted:
by: CoinDesk Crypto
#channels:: #All, #Business, #Nasdaq, #NasdaqCryptocurrencies, #Cryptocurrencies, #Crypto, #CoinDesk
Bitcoin, Ethereum, Dogecoin Tumble After Sam Bankman-Fried Found Guilty On All Charges: Analyst Says Apex Crypto To Enter 'Explosive' Phase As Long Term Indicators Flip Bullish
posted:
by: CoinDesk Crypto
#channels:: #All, #Business, #Nasdaq, #NasdaqCryptocurrencies, #Cryptocurrencies, #Crypto, #CoinDesk
Alnylam Pharma Reports Additional Positive Interim Phase 1 Results For Alzheimer's Disease Treatment
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Immutep : Efti+ Keytruda Generates Excellent OS Benefit In Phase II Trial In Metastatic NSCLC
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Regeneron : Dupixent Phase 3 Results Show Sustained Efficacy For Up To One Year In Children With EoE
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Merck Reveals Positive Results From Phase 3 KEYTRUDA Trials In Various Cancers
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets